ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026
The FDA-approved excipient N,N-dimethylacetamide improves survival and attenuates inflammatory pathways in a murine model of endotoxemia.
Zhihui Xiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.